167 related articles for article (PubMed ID: 28707493)
1. AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema.
Maeda H; Kikura-Hanajiri R; Kawamura M; Nagashima E; Yoshida KI
Clin Toxicol (Phila); 2018 Feb; 56(2):143-145. PubMed ID: 28707493
[TBL] [Abstract][Full Text] [Related]
2. Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption.
Kovács K; Kereszty É; Berkecz R; Tiszlavicz L; Sija É; Körmöczi T; Jenei N; Révész-Schmehl H; Institóris L
J Forensic Leg Med; 2019 Jul; 65():92-100. PubMed ID: 31128567
[TBL] [Abstract][Full Text] [Related]
3. Aspects related to analysis and medico-legal assessment in the context of the presence of synthetic cannabinoids in biological material based on the example of AB-CHMINACA.
Romańczuk A; Rojek S; Kula K; Kłys M
Arch Med Sadowej Kryminol; 2018; 68(4):266-280. PubMed ID: 31025844
[TBL] [Abstract][Full Text] [Related]
4. Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.
Angerer V; Jacobi S; Franz F; Auwärter V; Pietsch J
Forensic Sci Int; 2017 Dec; 281():e9-e15. PubMed ID: 29133010
[TBL] [Abstract][Full Text] [Related]
5. Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA.
Adamowicz P; Meissner E; Maślanka M
Clin Toxicol (Phila); 2019 Nov; 57(11):1103-1108. PubMed ID: 30806094
[No Abstract] [Full Text] [Related]
6. Identification and quantification of metabolites of AB-CHMINACA in a urine specimen of an abuser.
Wurita A; Hasegawa K; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Suzuki O; Watanabe K
Leg Med (Tokyo); 2016 Mar; 19():113-8. PubMed ID: 26257317
[TBL] [Abstract][Full Text] [Related]
7. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
Erratico C; Negreira N; Norouzizadeh H; Covaci A; Neels H; Maudens K; van Nuijs AL
Drug Test Anal; 2015 Oct; 7(10):866-76. PubMed ID: 25865117
[TBL] [Abstract][Full Text] [Related]
9. A case of intoxication with a mixture of synthetic cannabinoids EAM-2201, AB-PINACA and AB-FUBINACA, and a synthetic cathinone α-PVP.
Yamagishi I; Minakata K; Nozawa H; Hasegawa K; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
Leg Med (Tokyo); 2018 Nov; 35():44-49. PubMed ID: 30268690
[TBL] [Abstract][Full Text] [Related]
10. Determination of AB-CHMINACA and its metabolites in human hair and their deposition in hair of abusers.
Sim J; Cho HS; Lee J; In S; Kim E
J Pharm Biomed Anal; 2017 Jun; 140():162-168. PubMed ID: 28359963
[TBL] [Abstract][Full Text] [Related]
11. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
[TBL] [Abstract][Full Text] [Related]
12. Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.
Shanks KG; Clark W; Behonick G
J Anal Toxicol; 2016 Apr; 40(3):236-9. PubMed ID: 26755539
[TBL] [Abstract][Full Text] [Related]
13. An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA.
Tyndall JA; Gerona R; De Portu G; Trecki J; Elie MC; Lucas J; Slish J; Rand K; Bazydlo L; Holder M; Ryan MF; Myers P; Iovine N; Plourde M; Weeks E; Hanley JR; Endres G; St Germaine D; Dobrowolski PJ; Schwartz M
Clin Toxicol (Phila); 2015; 53(10):950-6. PubMed ID: 26555732
[TBL] [Abstract][Full Text] [Related]
14. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.
Carlier J; Diao X; Sempio C; Huestis MA
AAPS J; 2017 Mar; 19(2):568-577. PubMed ID: 28070717
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Synthetic Cannabinoid Deaths in State of Florida Prisoners.
Hvozdovich JA; Chronister CW; Logan BK; Goldberger BA
J Anal Toxicol; 2020 Apr; 44(3):298-300. PubMed ID: 31776572
[TBL] [Abstract][Full Text] [Related]
16. Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA.
Adamowicz P; Gieroń J
Clin Toxicol (Phila); 2016 Sep; 54(8):650-4. PubMed ID: 27227269
[TBL] [Abstract][Full Text] [Related]
17. Identification and quantification of predominant metabolites of synthetic cannabinoid MAB-CHMINACA in an authentic human urine specimen.
Hasegawa K; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Watanabe K; Suzuki O
Drug Test Anal; 2018 Feb; 10(2):365-371. PubMed ID: 28560823
[TBL] [Abstract][Full Text] [Related]
18. Toxic effects of AB-CHMINACA on liver and kidney and detection of its blood level in adult male mice.
Mohammad SA; Mousa REA; Gebril SM; Masoud KMM; Radwan RA
Forensic Toxicol; 2024 Jan; 42(1):7-17. PubMed ID: 37573525
[TBL] [Abstract][Full Text] [Related]
19. A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
Ivanov ID; Stoykova S; Ivanova E; Vlahova A; Burdzhiev N; Pantcheva I; Atanasov VN
Forensic Sci Int; 2019 Apr; 297():372-377. PubMed ID: 30850157
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the pharmacological properties of JWH-122 isomers and THJ-2201, RCS-4 and AB-CHMINACA in HEK293T cells and hippocampal neurons.
Costain WJ; Rasquinha I; Comas T; Hewitt M; Aylsworth A; Rouleau Y; Marleau V; Soo EC; Tauskela JS
Eur J Pharmacol; 2018 Mar; 823():96-104. PubMed ID: 29408093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]